151 related articles for article (PubMed ID: 20626736)
1. Evaluation of three different methods to prevent dialyzer clotting without causing systemic anticoagulation effect.
Richtrova P; Rulcova K; Mares J; Reischig T
Artif Organs; 2011 Jan; 35(1):83-8. PubMed ID: 20626736
[TBL] [Abstract][Full Text] [Related]
2. The AN69 ST haemodialysis membrane under conditions of two different extracorporeal circuit rinse protocols a comparison of thrombogenicity parameters.
Richtrova P; Opatrny K; Vit L; Sefrna F; Perlik R
Nephrol Dial Transplant; 2007 Oct; 22(10):2978-84. PubMed ID: 17597089
[TBL] [Abstract][Full Text] [Related]
3. Citrate anticoagulation control by ionized calcium levels does not prevent hemostasis and complement activation during hemodialysis.
Opatrný K; Richtrová P; Polanská K; Wirth J; Sefrna F; Brandl M; Falkenhagen D
Artif Organs; 2007 Mar; 31(3):200-7. PubMed ID: 17343695
[TBL] [Abstract][Full Text] [Related]
4. Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding.
Evenepoel P; Dejagere T; Verhamme P; Claes K; Kuypers D; Bammens B; Vanrenterghem Y
Am J Kidney Dis; 2007 May; 49(5):642-9. PubMed ID: 17472846
[TBL] [Abstract][Full Text] [Related]
5. The favorable effect of regional citrate anticoagulation on interleukin-1beta release is dissociated from both coagulation and complement activation.
Gabutti L; Ferrari N; Mombelli G; Keller F; Marone C
J Nephrol; 2004; 17(6):819-25. PubMed ID: 15593057
[TBL] [Abstract][Full Text] [Related]
6. A heparin-coated dialysis filter (AN69 ST) does not reduce clotting during hemodialysis when compared to a conventional polysulfone filter (F×8).
Sagedal S; Witczak BJ; Osnes K; Hartmann A; Os I; Eikvar L; Klingenberg O; Brosstad F
Blood Purif; 2011; 32(3):151-5. PubMed ID: 21659742
[TBL] [Abstract][Full Text] [Related]
7. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
Lavaud S; Canivet E; Wuillai A; Maheut H; Randoux C; Bonnet JM; Renaux JL; Chanard J
Nephrol Dial Transplant; 2003 Oct; 18(10):2097-104. PubMed ID: 13679486
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of coagulation and anti-Xa factor when using a heparin-coated AN69ST® dialyser.
Sánchez-Canel JJ; Pons-Prades R; Salvetti ML; Seores A; Vázquez M; Pérez-Alba A; Tamarit E; Calvo-Gordo C; Villatoro J
Nefrologia; 2012; 32(5):605-12. PubMed ID: 23013946
[TBL] [Abstract][Full Text] [Related]
9. Regional citrate anticoagulation for single-needle hemodialysis: a prospective clinical study.
Gubensek J; Buturovic-Ponikvar J; Ponikvar R
Blood Purif; 2007; 25(5-6):454-6. PubMed ID: 18057876
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulant-free Genius haemodialysis using low molecular weight heparin-coated circuits.
Frank RD; Müller U; Lanzmich R; Groeger C; Floege J
Nephrol Dial Transplant; 2006 Apr; 21(4):1013-8. PubMed ID: 16326745
[TBL] [Abstract][Full Text] [Related]
11. The clinical evaluation of low-dose heparin in haemodialysis: a prospective study using the heparin-coated AN69 ST membrane.
Chanard J; Lavaud S; Maheut H; Kazes I; Vitry F; Rieu P
Nephrol Dial Transplant; 2008 Jun; 23(6):2003-9. PubMed ID: 18156457
[TBL] [Abstract][Full Text] [Related]
12. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
[TBL] [Abstract][Full Text] [Related]
13. Simple citrate anticoagulation protocol for low flux haemodialysis.
Lim EK; Seow YT; Chen SE; Yang G; Liaw ME; Isaac S
BMC Nephrol; 2018 Jan; 19(1):16. PubMed ID: 29351783
[TBL] [Abstract][Full Text] [Related]
14. Regional citrate anticoagulation for hemodialysis: calcium-free vs. calcium containing dialysate - a randomized trial.
Buturovic-Ponikvar J; Cerne S; Gubensek J; Ponikvar R
Int J Artif Organs; 2008 May; 31(5):418-24. PubMed ID: 18609515
[TBL] [Abstract][Full Text] [Related]
15. Platelet activation in clinical haemodialysis: LMWH as a major contributor to bio-incompatibility?
Gritters M; Borgdorff P; Grooteman MP; Schoorl M; Schoorl M; Bartels PC; Tangelder GJ; Nubé MJ
Nephrol Dial Transplant; 2008 Sep; 23(9):2911-7. PubMed ID: 18364368
[TBL] [Abstract][Full Text] [Related]
16. Simplified citrate anticoagulation for high-flux hemodialysis.
Apsner R; Buchmayer H; Lang T; Unver B; Speiser W; Sunder-Plassmann G; Hörl WH
Am J Kidney Dis; 2001 Nov; 38(5):979-87. PubMed ID: 11684550
[TBL] [Abstract][Full Text] [Related]
17. Regional citrate anticoagulation for hemodialysis using a conventional calcium-containing dialysate.
Evenepoel P; Maes B; Vanwalleghem J; Kuypers D; Messiaen T; Vanrenterghem Y
Am J Kidney Dis; 2002 Feb; 39(2):315-23. PubMed ID: 11840372
[TBL] [Abstract][Full Text] [Related]
18. A noninferiority trial comparing a heparin-grafted membrane plus citrate-containing dialysate versus regional citrate anticoagulation: results of the CiTED study.
Meijers B; Metalidis C; Vanhove T; Poesen R; Kuypers D; Evenepoel P
Nephrol Dial Transplant; 2017 Apr; 32(4):707-714. PubMed ID: 28407129
[TBL] [Abstract][Full Text] [Related]
19. Intermittent saline flushes during haemodialysis do not alleviate coagulation and clot formation in stable patients receiving reduced doses of dalteparin.
Sagedal S; Hartmann A; Osnes K; Bjørnsen S; Torremocha J; Fauchald P; Kofstad J; Brosstad F
Nephrol Dial Transplant; 2006 Feb; 21(2):444-9. PubMed ID: 16234293
[TBL] [Abstract][Full Text] [Related]
20. Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge.
Gabutti L; Marone C; Colucci G; Duchini F; Schönholzer C
Intensive Care Med; 2002 Oct; 28(10):1419-25. PubMed ID: 12373466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
